Tags

Type your tag names separated by a space and hit enter

SU-E-I-40: Effective Dose Normalized to Dose Length Product for Pediatric and Adult Reference Phantoms in Computed Tomography Examinations.
Med Phys. 2012 Jun; 39(6Part4):3634.MP

Abstract

PURPOSE

To develop a set of conversion factors from dose length product (DLP) to effective dose (E) for pediatric and adult reference individuals undergoing computed tomography (CT) examinations.

METHODS

This study used 12 hybrid computational phantoms representing reference pediatric and adult individuals in compliance with the International Commission on Radiological Protection (ICRP) reference data. The phantoms were combined with a model of the Siemens Sensation 16 scanner, to compute organ doses from CT examinations using a radiation transport code, MCNPX2.7. Effective doses based on ICRP 60 and 103 tissue weighting factors were calculated. The DLP was derived from the scan length and Computed Tomography Dose Index (CTDI)vol. The resulting DLP-to-E conversion factors were analyzed.

RESULTS

The results consist in a set of DLP-to-E conversion factors for head, chest, abdomen, abdomen-pelvis, and chest-abdomen-pelvis CT examinations for newborn, 1-, 5-, 10-, 15-year-old and adult reference phantoms, for 80, 100 and 120 kVp and for ICRP 60 and 103 tissue weighting factors. The DLP-to-E factors decrease with smaller tube potential, with the greatest decrease for the head examinations for which values at 80 kVp are 20% smaller than at 120 kVp on average. The ICRP 103 weighting factors, compared to ICRP 60, Result in variations of DLP-to-E from 0.8 to 1.2-fold with a systematic increase for the chest, 1.14- fold on average, due to the increased breast weighting factor. The DLP-to-E factors for the body examinations are relatively similar to each other but 5 to 12-fold higher than for the head exam. The factors decrease with age until 15 years and then slightly increase for adult except for head.

CONCLUSIONS

An updated set of DLP-to-E conversion factors were established based on more realistic human phantoms and provide an improved accuracy to obtain effective dose from DLP for patients undergoing CT examinations.

Authors+Show Affiliations

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD. Department of Nuclear Engineering, Kyung Hee University, Gyeonggi-do, Korea. J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL.Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD. Department of Nuclear Engineering, Kyung Hee University, Gyeonggi-do, Korea. J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL.Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD. Department of Nuclear Engineering, Kyung Hee University, Gyeonggi-do, Korea. J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL.Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD. Department of Nuclear Engineering, Kyung Hee University, Gyeonggi-do, Korea. J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

28519533

Citation

Lamart, S, et al. "SU-E-I-40: Effective Dose Normalized to Dose Length Product for Pediatric and Adult Reference Phantoms in Computed Tomography Examinations." Medical Physics, vol. 39, no. 6Part4, 2012, p. 3634.
Lamart S, Kim K, Bolch W, et al. SU-E-I-40: Effective Dose Normalized to Dose Length Product for Pediatric and Adult Reference Phantoms in Computed Tomography Examinations. Med Phys. 2012;39(6Part4):3634.
Lamart, S., Kim, K., Bolch, W., & Lee, C. (2012). SU-E-I-40: Effective Dose Normalized to Dose Length Product for Pediatric and Adult Reference Phantoms in Computed Tomography Examinations. Medical Physics, 39(6Part4), 3634. https://doi.org/10.1118/1.4734755
Lamart S, et al. SU-E-I-40: Effective Dose Normalized to Dose Length Product for Pediatric and Adult Reference Phantoms in Computed Tomography Examinations. Med Phys. 2012;39(6Part4):3634. PubMed PMID: 28519533.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - SU-E-I-40: Effective Dose Normalized to Dose Length Product for Pediatric and Adult Reference Phantoms in Computed Tomography Examinations. AU - Lamart,S, AU - Kim,K, AU - Bolch,W, AU - Lee,C, PY - 2017/5/19/entrez PY - 2012/6/1/pubmed PY - 2012/6/1/medline KW - Anatomy KW - Computed tomography KW - Dosimetry KW - Image scanners KW - Tissues SP - 3634 EP - 3634 JF - Medical physics JO - Med Phys VL - 39 IS - 6Part4 N2 - PURPOSE: To develop a set of conversion factors from dose length product (DLP) to effective dose (E) for pediatric and adult reference individuals undergoing computed tomography (CT) examinations. METHODS: This study used 12 hybrid computational phantoms representing reference pediatric and adult individuals in compliance with the International Commission on Radiological Protection (ICRP) reference data. The phantoms were combined with a model of the Siemens Sensation 16 scanner, to compute organ doses from CT examinations using a radiation transport code, MCNPX2.7. Effective doses based on ICRP 60 and 103 tissue weighting factors were calculated. The DLP was derived from the scan length and Computed Tomography Dose Index (CTDI)vol. The resulting DLP-to-E conversion factors were analyzed. RESULTS: The results consist in a set of DLP-to-E conversion factors for head, chest, abdomen, abdomen-pelvis, and chest-abdomen-pelvis CT examinations for newborn, 1-, 5-, 10-, 15-year-old and adult reference phantoms, for 80, 100 and 120 kVp and for ICRP 60 and 103 tissue weighting factors. The DLP-to-E factors decrease with smaller tube potential, with the greatest decrease for the head examinations for which values at 80 kVp are 20% smaller than at 120 kVp on average. The ICRP 103 weighting factors, compared to ICRP 60, Result in variations of DLP-to-E from 0.8 to 1.2-fold with a systematic increase for the chest, 1.14- fold on average, due to the increased breast weighting factor. The DLP-to-E factors for the body examinations are relatively similar to each other but 5 to 12-fold higher than for the head exam. The factors decrease with age until 15 years and then slightly increase for adult except for head. CONCLUSIONS: An updated set of DLP-to-E conversion factors were established based on more realistic human phantoms and provide an improved accuracy to obtain effective dose from DLP for patients undergoing CT examinations. SN - 2473-4209 UR - https://www.unboundmedicine.com/medline/citation/28519533/SU_E_I_40:_Effective_Dose_Normalized_to_Dose_Length_Product_for_Pediatric_and_Adult_Reference_Phantoms_in_Computed_Tomography_Examinations_ L2 - https://doi.org/10.1118/1.4734755 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.